Ah, but will it kill the Beer Belly
Goodish news from the world of science:
Sirtris’ resveratrol formulation is now in Phase II clinical trials for diabetes. When it hits the market in four or five hears, David Sinclair [co-founder of Sirtris Pharmaceuticals, discovered the molecule resveratrol. Sirtis Pharmaceuticals was bought by GlaxoSmithKline for $720 million] said, “It’ll be on the market as a diabetes drug. It’ll have to sell for $3 or $4 a pill, in order to stay competitive.” The company is also working with other molecules — potential drugs — that are unrelated to resveratrol but also stimulate the SIRT1 gene. Some of the molecules could be up to 1,000 times more potent than resveratrol, he added. next big future
4 bucks a day for 3-13 extra years of life…a Mountain can of Stella a day. I’m there.
Written by jay on June 3rd, 2008 with
no comments.
Read more articles on culture and tech.
- [+] Digg: Feature this article
- [+] Del.icio.us: Bookmark this article
- [+] Furl: Bookmark this article